Abscess - Ithumbahttps://en.wikipedia.org/wiki/Abscess
I- Ithumba (Abscess) iqoqo lobovu olwenzeka ngaphakathi kwezicubu zomzimba. Izimpawu zamathumba zihlanganisa ububomvu, ubuhlungu, ukufudumala, nokuvuvukala. Ukuvuvukala kungase kuzwakale kugcwele uketshezi lapho ucindezelwa. Indawo yokubomvu ivame ukudlulela ngalé kwendawo yokuvuvukala.

Ngokuvamile zibangelwa ukutheleleka kwebhaktheriya. Ibhaktheriya elivame kakhulu elikhona yi-Staphylococcus aureus emelana ne-methicillin. Ukuxilongwa kwethumba lesikhumba kuvame ukwenziwa ngokuya ngokuthi libukeka kanjani futhi kuqinisekiswa ngokulisika livuleke. I-Ultrasound imaging ingase ibe usizo ezimweni lapho ukuxilongwa kungacacile. Emathumba azungeze ididi, i-computer tomography (CT) ingase ibaluleke ukubheka ukutheleleka okujulile.

Ukwelashwa okujwayelekile kwesikhumba esiningi noma amathumba ezicubu ezithambile ukuwuvula futhi kukhishwe amanzi ngenkathi usebenzisa ama-antibiotics. Ukumunca ubomvu ngenaliti ngokuvamile akwanele.

Amathumba esikhumba avamile futhi avame kakhulu eminyakeni yamuva. Izinto eziyingozi zihlanganisa ukusetshenziswa kwezidakamizwa ngokufakwa emthanjeni, amanani abikwe afinyelela ku-65% phakathi kwabasebenzisi. Ngo-2005 e-United States, abantu abayizigidi ezingu-3.2 baya emnyangweni wezimo eziphuthumayo ukuze bathole ithumba. E-Australia, cishe abantu abayi-13,000 balaliswa esibhedlela ngo-2008 nalesi simo.

○ Ukwelashwa
Ukwelapha amathumba ngemithi ethengwayo kunzima ezikhathini eziningi. Uma izimpawu ezinjengomkhuhlane nokugodola zivela kuwo wonke umzimba, sicela uthintane nodokotela ngokushesha ngangokunokwenzeka.

☆ Emiphumeleni ka-2022 ye-Stiftung Warentest evela eJalimane, ukwaneliseka kwabathengi nge-ModelDerm bekungaphansi kancane kunokuxhumana okukhokhelwayo kwe-telemedicine.
  • inflamed epidermal cyst. Indawo emnyama ixhunywe ne-cyst engaphansi.
  • Kulesi simo sokuvuvukala kwezihlathi, kungenzeka futhi kucatshangelwe ukuthi kungenzeka i-cyst epidermal.
  • Ifomu elinzima le-Ithumba (Abscess) lingashiya isibazi. I-erythema encane ezungeze isilonda ibonisa ukuthi ukutheleleka kusesimweni sokuxazululeka.
  • Ithumba (Abscess) ― ezinsukwini ezinhlanu ngemva kokusikwa nokukhipha amanzi
  • Ichashaza elimnyama engxenyeni engenhla yethumba liphakamisa ukuthi epidermal cyst.
References Current Treatment Options for Acute Skin and Skin-structure Infections 30957166 
NIH
Abantu abaningi baya emagumbini aphuthumayo ukuze bathole izifo zesikhumba ezibangelwa amagciwane. Staphylococcus aureus igciwane eliyinhloko elidala lezi zifo, futhi kuya kuba nzima ukuyelapha ngenxa yokuvela kwe- community-associated methicillin-resistant Staphylococcus aureus (MRSA) .
Acute bacterial skin and skin-structure infections are a common reason for seeking care at acute healthcare facilities, including emergency departments. Staphylococcus aureus is the most common organism associated with these infections, and the emergence of community-associated methicillin-resistant Staphylococcus aureus (MRSA) has represented a considerable challenge in their treatment.
 Prevalence and Therapies of Antibiotic-Resistance in Staphylococcus aureus 32257966 
NIH
Staphylococcus aureus ingahlukaniswa ngezinhlobo ezimbili ngokuya ngempendulo yazo kuma-antibiotics: methicillin-sensitive Staphylococcus aureus (MSSA) and methicillin-resistant Staphylococcus aureus (MRSA) . Emashumini ambalwa eminyaka adlule, ngenxa yokuvela kwamagciwane kanye nokusetshenziswa ngokweqile kwama-antibiotics, ukumelana kwe- S. Aureus kwezidakamizwa bekulokhu kukhuphuka, okuholela ekwenyukeni komhlaba wonke kumazinga okutheleleka angu- MRSA.
According to the sensitivity to antibiotic drugs, S. aureus can be divided into methicillin-sensitive Staphylococcus aureus (MSSA) and methicillin-resistant Staphylococcus aureus (MRSA). In recent decades, due to the evolution of bacteria and the abuse of antibiotics, the drug resistance of S. aureus has gradually increased, the infection rate of MRSA has increased worldwide.
 Treatment of severe skin and soft tissue infections: a review 29278528 
NIH
To review the salient features of the management of severe skin and soft tissue infections (SSTIs), including toxic shock syndrome, myonecrosis/gas gangrene, and necrotizing fasciitis.